Using knowledge:
To support the development and use
of knowledge to create health benefit
We are committed to the principle of putting research into practice.
We aim to encourage the application of research knowledge for health benefit.
Over the next five years, in order to ensure that the enormous potential
provided by rapid advances in biomedical research is realised, we aim to
increase our annual spend in this area.
AIMS AND OBJECTIVES
2
Objective 2.1 Objective 2.2
To increase the opportunities for the development To work with relevant partners to ensure that the
of products, devices and enabling technologies outcomes of research are considered in changes
for health benefit to clinical practice, healthcare and public policy
We provide Translation Awards to researchers from We work with governments in the UK and developing
across a broad spectrum of science and technology countries to facilitate the use of research outputs to
to enable them to advance promising innovations inform health policy and implementation. In partnership
to a stage at which they become attractive to the with the UK NHS and the Scottish Executive, we have
commercial sector for further development. We also also funded five Clinical Research Facilities. These major
work with inventors, and their institutions or early-stage sites for patient-oriented research aim to ensure that
companies, to maximise the opportunities for public advances in biomedical research feed into improvements
health benefit arising from the application of intellectual in healthcare and good clinical practice.
property derived from biomedical research. We provide
support for the Wellcome Trust Sanger Institute in the Over the next five years, we intend to:
translation of its research for health benefit, and the use • work in partnership with key organisations to
of its intellectual property rights for the public benefit. capitalise on the initial successes of the Clinical
Research Facilities, ensuring that this area of
Over the next five years, we intend to: work has the greatest impact on good clinical
• seed the broadening of drug discovery research practice and healthcare
with new major awards for projects that
• increase the potential for the outcomes of
complement industry and have the potential
research to inform policy development and
for clinical application
healthcare practice. Ways in which we might
• support translational research in neglected achieve this include:
diseases in order to create new opportunities for
• developing more effective means to engage policy
product development by public–private partnerships
makers and other user groups with scientific
in global health or other interested parties
advances and related ethical issues
• work with the independent advisers of our
• supporting researchers to promote the clinical,
Technology Transfer Strategy Panel and Challenge
healthcare and public policy take-up of their
Committee to identify further priorities and
own research
strategies for optimising the impact of translational
research funding.
• reviewing and strengthening our work to
translate the latest outcomes from research into
training materials for healthcare professionals in
developing countries.
12 STRATEGIC PLAN 2005–2010 AIMS AND OBJECTIVES
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32